Endexx’s Division HYLA Secures Eight Country Territory Deal
CAVE CREEK, AZ, June 15, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Endexx® Corporation (OTC: EDXC), a provider of innovative plant-based wellness and nutritional products, today announced its HYLA™ division has secured an eight country distribution agreement for Hyla “No-Nicotine” vape products in the greater “Middle East Territories”. SAHARA PACIFIC FOR ELECTRONIC CIGARETTES & ACCESSORIES TRADING Company (aka Sahara Trading) to organize and lead distribution in the territory targeting a minimum 100,000 units per month as the expansion roles out. According to “World Population Review” there are nearly 500 million people living in 17 Middle East Countries of which an average of 20% of the population smokes daily. Statistics cited by “BioMed Central” indicate that 45-51 percent of the population will utilize vape in their lifetime. No-nicotine vape products in the Middle East offer a tremendous opportunity for Hyla products with its unique all-natural formulations and established distribution partner Sahara Trading.
HYLA Middle East opportunities:
490 million people live in the known 17 Middle East countries
20% of this population smokes daily or 98 million regular smokers
HYLA no-nicotine products now available in the 10 most populous countries in the region
“Consolidating distribution for these eight countries with Sahara Trading as our partner allows for rapid deployment of Hyla products in the Middle East region,” said Todd Davis CEO Endexx. “International expansion and distribution points into markets with mass consumer product appeal accelerates our ability to grow revenues exponentially over the coming 3-5 years,” said Davis.
www.endexx.com & www.cbdunlimited.com
About Endexx Corporation
Endexx Corporation develops and distributes all natural, plant-derived wellness products and topical skincare products. Its products vary from balms, creams, lotions, butters, masks, scrubs, and oils, all with the shared purpose of healthy skin and grooming wellness. The science behind these products involves a decade of clinical research in the field and lab work to provide functional formulation with ingredients for optimal absorption and support of skin health. www.endexx.com
Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995
We caution that any forward-looking statements (as such term is defined in the U.S. Private Securities Litigation Reform Act of 1995) contained in this press release or made by us, our management, or our spokespeople involve risks and uncertainties and are subject to change based on various factors, many of which are beyond our control. Accordingly, our future performance and financial results may differ materially from those expressed or implied in any such forward-looking statements. Forward-looking statements include, without limitation, statements regarding our future operating results, the implementation and impact of our strategic plans, and our ability to meet environmental, social, and governance goals. Words such as “estimate,” “commit,” “target,” “goal,” “project,” “plan,” “believe,” “seek,” “strive,” “expect,” “anticipate,” “intend,” “potential” and any similar expressions may identify forward-looking statements. Risks associated with the following factors, among others, could affect our financial performance and cause actual results to differ materially from those expressed or implied in any forward-looking statements.
Except as may be required by law, we assume no obligation and do not intend to make publicly available any update or other revisions to any of the forward-looking statements contained in this press release to reflect circumstances existing after the date of this press release or to reflect the occurrence of future events, even if experience or future events make it clear that any expected results expressed or implied by those forward-looking statements will not be realized. More information on potential factors that could affect our results is included “Risk Factors” in our amended Annual Report on Form 10-K/A filed with the Securities and Exchange Commission on June 9, 2023.
For further information, please contact:
Endexx Corporation
Endexx@endexx.com
480-595-6900
